As NICE looks to change its evaluation criteria for new medications, taking a broader, societal view of their value, many remain skeptical of the results. Will it mean fewer rejections? What will it mean for patients towards the end of their lives? NICE consultation will remain open thru June 20, before final changes will be made and implemented in autumn. More information available here. (Source: Thomas Meek, PMLiVE, 3/27/14).
You are here: / / NICE Proposes A More Flexible Approach To Drug Funding, But Will It Be Enough?